Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Adhesion of Test Estradiol/Levonorgestrel TDS vs Climara Pro in Postmenopausal Women
NCT07851649Phase 1Completed
- Sponsor
- Corium
- Start
- Jul 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estradiol and avatrombopag in postmenopause (2 arms), sponsored by Corium. Primary endpoints: Maximum Plasma Concentration of Baseline-Corrected Estradiol, Area Under the Plasma Concentration-Time Curve From Time Zero to Last Measurable Concentration of Baseline-Corrected Estradiol and 5 more. Started Jul 2026; status: completed.
02
Drugs
estradiolavatrombopag
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT07851649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07851649.